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Introduction
Recruiting representative population groups with a specific
disease is a challenge. In jurisdictions with no existing or
no access to a database including individual disease diag-
noses (e.g., electronic medical records), there are few
satisfying strategies. Usually, population health surveys do
not provide enough diagnostic information and may not
allow recruiting large enough samples to study a specific
disease. Registries or clinical cohorts may exist for specific
diseases, but are often not truly population-based.
Recruitment from patients’ associations and physicians’
practices may also be selective. In addition, the latter is
difficult to run in busy primary care clinics. Finally, the
type of information and the possibility to access health
insurances’ databases may preclude their use. For diseases
that require treatment involving pharmacies regularly, we
propose to recruit patients in community pharmacies; this
has been seldom described (Knoester et al. 2005; Van
Wieren-de Wijer et al. 2009). In the canton of Vaud,
Switzerland (*700,000 residents), we have applied such
an approach to conduct a survey designed to describe the
current population of diabetic patients and to assess the
quality of their care. This survey was developed within the
framework of a regional diabetes program that started in
the summer of 2010 (Hagon-Traub et al. 2010), as one of
many such programs implemented to tackle the chronic
diseases epidemic (Nolte et al. 2008).
The aim of this Hints and Kinks is to present a phar-
macy-based approach of recruiting diabetic patients.
Methods
Taking into account the clustering of data by pharmacies
(40 pharmacies recruiting each 15 patients, intra-class
correlation 0.05, alpha 0.05, beta 0.2), 600 diabetic patients
were considered enough to get a good precision around our
primary outcomes (mean HbA1C, mean Physical and
Mental summary score of the SF-12, % of patients with
specific annual checks).
To optimize the representativeness of the sample of
diabetic patients, we decided to randomly select pharma-
cies. Expecting a participation rate of 50 %, we first chose
80 pharmacies out of the 254 ones registered in the canton
in April 2011 (130 independent and 124 chain pharmacies).
Since we did not reach our 40 target pharmacies, we
redrew another sample of 60. After this two-step procedure,
56 pharmacies accepted to participate. Both participating
and non-participating pharmacies were asked to fill in a
brief questionnaire on their practice characteristics (phar-
macy type, pharmacy size and pharmacy location).
Reasons for participation refusal were also asked.
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In September 2011, pharmacists recruited consecutive
non-institutionalized adult diabetic patients (C18 years,
type 1 or 2 diabetes, disease duration C12 months) who
were visiting the pharmacy with a prescription for oral anti-
diabetic drugs, insulin, glycemic strips or glucose meter.
Women with gestational diabetes, patients not residing in
the canton of Vaud, not speaking and understanding French
well enough or presenting obvious cognitive impairment
were excluded. The latter two eligibility criteria were
subjectively assessed by the pharmacists. Age was recor-
ded according to data on the prescription, and diabetes
duration was asked to the patient. Physicians did not par-
ticipate in the recruitment phase but were asked to fill in a
short questionnaire (clinical and laboratory data), if
patients did share their contact details.
A first letter was sent to all physicians and pharmacists of
the canton, announcing the study. Another letter explaining
the recruitment process to the randomly selected pharmacies
was then sent. The recruitment was expected to last less than
10 min per patient, and pharmacies would receive a CHF 5
incentive for each questionnaire returned. Finally, we orga-
nized a meeting with pharmacists, to launch the study,
answer final questions, and provide all needed documents;
those who were not able to attend the meeting were seen in
person during the same week. We contacted pharmacists
weekly during the recruitment period. Since the patients’
participation rate was lower than expected (i.e. less than 600
questionnaires sent back), the recruitment period was
extended from 4 to 6 weeks. During the final phone call,
main reasons for ineligibility, main barriers to recruitment,
and main reasons for patients’ refusal were investigated.
The protocol was approved by the Canton’s Ethics
Committee of Research on Human Beings.
Results
The characteristics of participating and non-participating
pharmacies (Table 1) did not differ significantly except for
size of the pharmacy. Lack of time (68 %) and not having
enough diabetic patients (23 %) were the main reasons for
refusing to participate.
During the recruitment period, 809 of 1,013 eligible
patients accepted to receive the questionnaire from a
pharmacy (Fig. 1); approximately 17 % of approached
patients (0–52 % depending on pharmacy) were ineligible.
Finally, 406 patients returned the paper-questionnaire,
leading to an estimated patients’ participation rate of
50.2 % (406/809). At the end of the 6-week period, main
reported barriers for recruitment were ineligibility of
patients (34 %), duration of recruitment period too short
(25 %), difficulty to propose the study to patients (25 %),
and difficulty to motivate the pharmacy’s team (14 %).
Discussion
Recruitment of diabetic patients by pharmacies was feasi-
ble and satisfactory. Even if we did not reach our 600
targeted patients, this did not modify the precision of our
point estimates because we got a larger number of clusters
(pharmacies) and our dichotomous outcomes estimates had
been conservative. This lower recruitment rate might be
explained both by pharmacy- and patient-related barriers.
In fact, more patients than expected were ineligible
because they did not master French well enough, possibly
presented cognitive impairment, or were not residing in the
canton. Despite clear recruitment recommendation and
frequent contacts with pharmacists, it remains unclear,
however, how eligibility criteria were actually interpreted
and applied, and whether patients were truly ineligible or
Table 1 Characteristics of randomly selected (n = 140) participat-
ing and non-participating pharmacies of the canton of Vaud
(Switzerland, 2011)
Participating
pharmacies
(n = 56)
Non-
participating
pharmaciesa
(n = 47)
All
pharmacies
(N = 254)
Pharmacy type
Independent 37 (66 %) 29 (62 %) 130 (51 %)
Chain (Sunstore,
Amavita, Capitol,
Pharmacie Plus)
17 (30 %) 18 (38 %) 124 (49 %)
Other pharmacy
type
2 (4 %) 0 (0 %) 0 (0 %)
Pharmacy location
Rural 13 (23 %) 6 (13 %) NA
Urban 26 (47 %) 25 (53 %) NA
Semi-urban 17 (30 %) 16 (34 %) NA
Pharmacy size
Small (\100
patients/day)
11 (20 %) 19 (40 %) NA
Medium (100–200
patients/day)
24 (43 %) 18 (38 %) NA
Large ([200
patients/day)
21 (38 %) 10 (22 %) NA
Pharmacist participation in
Quality circles 15 (27 %) 8 (17 %) NA
Current chronic
disease
management
programs
18 (32 %) 17 (36 %) NA
Other non-specified
program
6 (11 %) 9 (19 %) NA
None 17 (30 %) 13 (28 %) NA
NA not available
a 37 non-participating pharmacies did not provide information
regarding their practice
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whether pharmacists ‘‘unintentionally applied selection
criteria’’ (Knoester et al. 2005).
One important issue with this type of recruitment is the
representativeness of such a sample. When comparing our
sample to 260 known and treated diabetic patients aged
35–75 years, participating in a population-based cohort of
residents of Lausanne (CoLaus), main town of the canton
of Vaud, we noticed that they were rather similar on a few
comparable variables (women 41 vs. 33 %, mean age 64
vs. 61 years, tertiary level education 25 vs. 20 %, current
smokers 16 vs. 23 %, overweight and obesity 82 vs. 84 %,
in our sample vs. the CoLaus sample, respectively)
(P. Marques-Vidal, personal communication). Slight dif-
ferences might be accounted for by differences in age
ranges of the target population. This shows that in a same
region, two recruitment strategies led to similar samples of
diabetic participants. This similarity speaks against a major
representativeness bias. However, both samples include
only patients willing to participate in studies.
We chose this form of recruitment to involve physicians
and pharmacists in the survey procedure, to minimize
selection bias of both participating physicians and patients,
to include patients treated by a variety of physicians and to
limit the burden of physicians known to be very busy. In
addition, our multidisciplinary working group hypothe-
sized that pharmacist would be more ready to participate in
the recruitment of patients than physicians. With regard to
the latter reason, Swiss examples of diabetes screening
projects in community pharmacies were promising (Bovet
et al. 2011; Hersberger et al. 2006). Indeed, the recent
pharmacy-based screening and awareness campaign for
diabetes and cardiovascular risk factors in the canton of
Vaud showed that, in 2010, 78 % of registered pharmacies
agreed to participate, allowing 4,222 individuals to be
screened (Bovet et al. 2011). In that example, however
(and others in the literature), pharmacists were actively
participating in the intervention. They were not only asked
to recruit patients and distribute questionnaires, but were
actually assessing several chronic diseases risk factors and
behaviors.
Informing, inciting and training pharmacists to take part
in clinical research projects, prolonging and carefully
monitoring the recruitment period, finding incentives to
increase the pharmacists’ and patients’ motivation to par-
ticipate could improve the yield of this recruitment method.
In fact, participation in an intervention, where pharmacists
would not only recruit patients but be actively involved in
patients care, may be an interesting alternative. It may
match pharmacists’ interest to be further involved in new
roles and help them overcome time constraints.
Easing recruitment of patients in primary care settings is
needed. Pharmacy-based recruitment represents a valuable
option that should be further developed and tested, par-
ticularly, since there is increasing evidence that
pharmacists may help manage chronic diseases (McLean
et al. 2008; Santschi et al. 2011).
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Fig. 1 Recruitment flow
diagram (Canton of Vaud,
Switzerland, 2011)
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